YOLFTbeta
Nantong Jinghua Pharmaceutical Co Ltd

Nantong Jinghua Pharmaceutical Co Ltd

002349 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

6.85CNY-0.15 (-2.14%)

Price History

Full chart

Market Stats

Previous Close7.00
Open6.99
Day Range6.80 – 7.01
52-Week Range5.99 – 9.26
Volume20.98M
Market Cap7.11B
P/E (TTM)31.67
Forward P/E26.18
EPS0.27
Dividend Yield1.08%
Beta0.14
50-Day Avg7.47
200-Day Avg7.31

About

Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products. It also provides Jidesheng antivenomous tablets, Nantong Wang's baby health pill, Ningning ZhengChaihu granules, Dachaihu granules, Gubenkechuan tablets, dizziness treatment syrup, and Jinqiaomai tablets; and APIs, such as phenobarbital, primidone, fluorouracil, phenylbutazone, flucytosine, piroxicam, tenoxicam, and propylthiouracil. In addition, the company engages in enterprise management; technical services; goods and technology import and export; chemical wholesale; pharmaceutical retail; medical devices equipment sales; provision of cosmetics and skincare products; and investment activities. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is headquartered in Nantong, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jian Cheng
  • Employees1.46K
  • HeadquartersBuilding A, Guocheng Life Plaza Office Building, Nantong, China, 226001, China
  • Websitehttps://www.ntjhzy.com

Leadership

  • Mr. Jian ChengGM, CFO & Director · b. 1979
  • Mr. Yuxiang WuVice Chairman · b. 1969
  • Mr. Jianfeng WangBoard Secretary · b. 1977
  • Mr. Qianyong ZhuDeputy General Manager · b. 1970
  • Ms. Yan Juan ShenDeputy General Manager · b. 1976
  • Li ZhaoAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue209.84M229.55M234.87M259.39M274.32M375.50M665.38M732.62M577.75M780.33M881.49M1.12B1.35B1.16B1.28B1.36B1.57B1.51B1.40B1.46B
Growth (%)-+9.40%+2.32%+10.44%+5.76%+36.88%+77.20%+10.10%-21.14%+35.06%+12.96%+27.16%+20.86%-14.57%+10.71%+5.97%+15.85%-3.90%-7.25%+4.13%
Cost of Revenue127.48M129.56M128.61M133.37M133.39M230.32M474.10M528.42M361.08M483.25M447.71M565.37M708.28M738.16M695.09M739.21M847.06M781.18M719.73M702.40M
Gross Profit82.36M99.99M106.26M126.01M140.93M145.18M191.28M204.20M216.68M297.09M433.78M555.55M646.43M419.23M586.27M618.66M726.00M730.58M682.36M757.56M
Gross Margin39.25%43.56%45.24%48.58%51.37%38.66%28.75%27.87%37.50%38.07%49.21%49.56%47.72%36.22%45.75%45.56%46.15%48.33%48.67%51.89%
Operating Expense64.37M66.92M74.66M86.49M92.00M106.69M149.08M164.95M176.83M204.10M240.09M384.66M352.95M917.39M522.98M438.16M474.51M399.72M387.30M473.20M
Operating Income17.98M33.07M31.60M39.53M48.93M38.49M42.20M39.25M39.84M92.99M193.69M170.90M293.47M-498.16M63.28M180.51M251.48M330.85M295.06M284.36M
Operating Margin8.57%14.40%13.46%15.24%17.84%10.25%6.34%5.36%6.90%11.92%21.97%15.25%21.66%-43.04%4.94%13.29%15.99%21.89%21.04%19.48%
EBITDA38.89M52.92M44.96M49.89M59.26M66.54M91.52M71.09M99.44M146.62M267.83M285.94M377.06M-393.30M167.65M293.41M365.34M416.74M369.86M384.76M
EBITDA Margin18.53%23.05%19.14%19.23%21.60%17.72%13.75%9.70%17.21%18.79%30.38%25.51%27.83%-33.98%13.08%21.61%23.22%27.57%26.38%26.35%
Net Income11.80M25.59M26.16M32.80M42.64M48.10M49.22M35.60M39.47M78.08M165.03M175.32M229.67M-393.62M110.99M160.70M212.23M247.70M212.65M219.28M
Net Income Margin5.62%11.15%11.14%12.65%15.54%12.81%7.40%4.86%6.83%10.01%18.72%15.64%16.95%-34.01%8.66%11.83%13.49%16.38%15.17%15.02%
R&D-----11.13M14.82M14.37M15.71M26.64M42.94M37.67M40.32M82.76M52.05M74.76M86.98M64.62M61.79M64.99M
R&D as % of Total Revenue-----2.96%2.23%1.96%2.72%3.41%4.87%3.36%2.98%7.15%4.06%5.51%5.53%4.27%4.41%4.45%
Interest Expense4.86M2.83M2.87M969.73K23.69K1.16M2.18M3.08M8.70M4.17M6.04M5.28M10.17M25.99M19.91M13.23M7.06M2.84M1.60M572.45K
Interest Expense % of Total Revenue2.32%1.23%1.22%0.37%0.01%0.31%0.33%0.42%1.51%0.53%0.68%0.47%0.75%2.25%1.55%0.97%0.45%0.19%0.11%0.04%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets198.19M200.11M195.95M220.37M611.41M780.53M957.71M1.07B1.89B2.51B2.53B3.24B3.40B2.94B3.16B3.20B3.04B3.19B3.30B3.57B
Total Liabilities128.18M108.25M77.29M83.26M66.96M144.23M242.84M328.99M351.96M272.27M227.87M594.47M705.27M793.63M669.29M628.54M417.93M380.75M344.66M421.13M
Total Equity70.00M91.85M118.65M137.10M544.44M585.14M624.45M669.86M1.38B2.04B2.15B2.28B2.28B1.85B2.11B2.24B2.40B2.44B2.58B2.75B
Cash9.89M22.88M24.73M57.09M401.80M365.96M201.95M135.76M866.29M484.83M386.17M387.86M211.46M300.14M581.32M651.59M933.27M921.76M1.01B854.92M
Total Debt61.03M40.00M30.00M25.00M--17.80M75.00M119.94M110.06M21.08M290.00M414.00M510.50M201.54M194.59M22.62M21.36M10.63M-
Net Debt51.14M17.12M5.27M-32.09M-401.80M-365.96M-184.15M-60.76M-746.35M-374.77M-365.09M-97.86M202.54M210.36M-284.42M-457.00M-910.65M-900.40M-1.00B-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow22.18M33.86M17.13M57.76M41.06M41.45M77.25M-54.94M45.70M-76.01M343.80M75.92M83.43M285.38M328.22M305.57M358.39M291.31M311.02M340.87M
Investing Cash Flow-2.91M8.83M-2.36M-4.40M-35.66M-69.48M-212.32M-43.51M-23.70M-378.81M-314.14M-440.97M-158.10M-245.34M-123.41M-68.97M108.59M-212.37M-105.81M-
Financing Cash Flow-23.93M-29.07M-12.89M-20.99M339.31M-7.80M-35.99M39.37M707.54M61.94M-126.42M373.32M-99.81M50.20M79.78M-176.21M-182.05M-94.16M-108.02M-
Capital Expenditure2.95M4.44M2.36M4.40M35.89M100.89M190.26M57.62M28.83M58.82M245.10M441.17M160.25M255.35M118.46M80.55M61.59M28.38M30.92M20.32M
Free Cash Flow19.23M29.42M14.77M53.35M5.17M-59.44M-113.01M-112.56M16.87M-134.83M98.70M-365.25M-76.82M30.04M209.75M225.02M296.80M262.93M280.10M320.54M
Dividends Paid8.93M8.04M2.89M15.99M8.04M8.00M13.29M12.88M14.17M29.41M30.82M69.14M57.38M61.01M19.95M44.50M48.85M65.98M75.55M65.24M
FCF to OCF86.69%86.87%86.20%92.38%12.58%-143.42%-146.30%204.88%36.91%177.38%28.71%-481.08%-92.07%10.52%63.91%73.64%82.82%90.26%90.06%94.04%
Dividend Paid to FCF46.46%27.33%19.59%29.97%155.67%-13.46%-11.76%-11.44%84.02%-21.82%31.22%-18.93%-74.69%203.12%9.51%19.78%16.46%25.10%26.97%20.35%

Earnings

Report DateMar 31, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jul 30, 2014Oct 26, 2014Feb 15, 2015Apr 17, 2015Jul 24, 2015Oct 19, 2015Feb 1, 2016Apr 11, 2016Aug 29, 2016Oct 24, 2016Feb 8, 2017Apr 20, 2017Jun 30, 2017Oct 29, 2017Feb 27, 2018Apr 16, 2018Aug 9, 2018Oct 29, 2018Feb 17, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 31, 2020Oct 30, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Jun 7, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------0.080.05----------------------------------------------
EPS Actual0.020.030.010.040.020.010.010.040.020.010.010.030.020.010.010.020.020.030.030.020.020.020.040.050.050.040.060.040.080.040.050.070.080.050.070.080.07-0.42-0.220.070.06-0.000.010.070.060.030.040.080.080.050.050.110.080.050.060.090.080.040.060.080.080.060.050.080.09
Surprise------------------62.50%-40.00%----------------------------------------------
Timing----------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market--------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap7.11B
Enterprise Value5.96B
Trailing P/E31.67
Forward P/E26.18
PEG Ratio0.00
Price / Sales4.79
Price / Book2.52
EPS0.27
Book Value3.47
Revenue (TTM)1.48B
Gross Profit (TTM)764.09M
EBITDA368.39M
Profit Margin15.15%
Operating Margin23.97%
Return on Equity8.80%
Return on Assets5.15%
Shares Outstanding831.13M
Shares Float506.92M
Beta0.14
Dividend Yield1.08%
Dividend Rate0.09
Payout Ratio32.69%

Dividends

20261×
0.09May 29, 2026
20251×
0.08Jun 6, 2025
20241×
0.09Jun 12, 2024
20231×
0.08Jun 9, 2023
20221×
0.06Jun 13, 2022
20211×
0.04Jun 30, 2021
20191×
0.05May 8, 2019
20181×
0.05May 10, 2018
20171×
0.04Mar 14, 2017
20161×
0.03Mar 8, 2016
20151×
0.03Apr 10, 2015
20141×
0.02Jun 4, 2014
20131×
0.02Jun 28, 2013
20121×
0.02May 2, 2012
20111×
0.01Mar 1, 2011
20101×
0.01Jun 1, 2010

Stock Splits

  • Mar 14, 201720:10
  • Mar 8, 201615:10
  • May 2, 201220:10
  • Mar 1, 201112.5:10